Literature DB >> 17300129

Unequal crossover recombination - population screening for PHOX2B gene polyalanine polymorphism using CE.

Chia-Cheng Hung1, Yi-Ning Su, Po-Nien Tsao, Pau-Chung Chen, Shio-Jean Lin, Cheng-Hui Lin, Shu-Chi Mu, Chieh-An Liu, Ying-Chao Chang, Win-Li Lin, Wu-Shiun Hsieh, Su-Ming Hsu.   

Abstract

Congenital central hypoventilation syndrome (CCHS) is a rare neurological disorder characterized by abnormal autonomic central nervous system control of breathing during sleep. Mutations in the paired-like homeobox 2B (PHOX2B) gene, including point mutation, frameshift, and polyalanine expansion, are associated with the pathogenesis of CCHS. In this study, PHOX2B mutations were analyzed in seven CCHS patients, their family members, and 1520 healthy individuals from the general population using CE to provide high sensitivity and resolution screening for the PHOX2B polyalanine polymorphism. Seven mutations in the PHOX2B gene, including two frameshift mutations and five polyalanine expansions in the 20-residue polyalanine tract, were identified. The various phenotypes observed in CCHS patients with PHOX2B mutations suggest that the size of the expansion allele is associated with the CCHS risk. In addition, significant differences were found in allele and genotype distributions between the healthy individuals. Alleles (GCN)(20) and (GCN)(15) had the highest population incidence rates of 94.84 and 4.51%, respectively, with the remaining alleles, (GCN)(13) and (GCN)(7), accounting for 0.59 and 0.06%, respectively. Therefore, it has been demonstrated that CE can be used to improve the detection of polyalanine expansions in the PHOX2B gene. The attractive alternative method is a promising tool for the detection of disorders involving trinucleotide repeat tracts.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17300129     DOI: 10.1002/elps.200600383

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  7 in total

1.  Congenital central hypoventilation syndrome due to PHOX2B mutation in a Saudi child: a case report.

Authors:  Muslim Mohammed Al Saadi
Journal:  Sleep Breath       Date:  2010-11-19       Impact factor: 2.816

Review 2.  Executive summary of respiratory indications for polysomnography in children: an evidence-based review.

Authors:  Merrill S Wise; Cynthia D Nichols; Madeleine M Grigg-Damberger; Carole L Marcus; Manisha B Witmans; Valerie G Kirk; Lynn A D'Andrea; Timothy F Hoban
Journal:  Sleep       Date:  2011-03-01       Impact factor: 5.849

3.  PHOX2B mutations in patients with Ondine-Hirschsprung disease and a review of the literature.

Authors:  Min-Jung Kwon; Gi-Hyuck Lee; Myoung-Keun Lee; Ji-Youn Kim; Hye Soo Yoo; Chang-Seok Ki; Yun Sil Chang; Jong-Won Kim; Won Soon Park
Journal:  Eur J Pediatr       Date:  2011-03-04       Impact factor: 3.183

Review 4.  Congenital central hypoventilation syndrome and the PHOX2B gene: a model of respiratory and autonomic dysregulation.

Authors:  Pallavi P Patwari; Michael S Carroll; Casey M Rand; Rajesh Kumar; Ronald Harper; Debra E Weese-Mayer
Journal:  Respir Physiol Neurobiol       Date:  2010-06-30       Impact factor: 1.931

5.  Congenital central hypoventilation syndrome in neonates: report of fourteen new cases and a review of the literature.

Authors:  Mei Mei; Lin Yang; Yulan Lu; Laishuan Wang; Guoqiang Cheng; Yun Cao; Chao Chen; Liling Qian; Wenhao Zhou
Journal:  Transl Pediatr       Date:  2021-04

6.  Contributions of PHOX2B in the pathogenesis of Hirschsprung disease.

Authors:  Raquel María Fernández; Yves Mathieu; Berta Luzón-Toro; Rocío Núñez-Torres; Antonio González-Meneses; Guillermo Antiñolo; Jeanne Amiel; Salud Borrego
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

7.  Mutation spectrum of 122 hemophilia A families from Taiwanese population by LD-PCR, DHPLC, multiplex PCR and evaluating the clinical application of HRM.

Authors:  Shin-Yu Lin; Yi-Ning Su; Chia-Cheng Hung; Woei Tsay; Shyh-Shin Chiou; Chieh-Ting Chang; Hong-Nerng Ho; Chien-Nan Lee
Journal:  BMC Med Genet       Date:  2008-06-20       Impact factor: 2.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.